Effects of Anesthesia Type on QoR-40

NCT06423313 | Completed

• 1 other identifier: 2024/07-1
• Study Type: observational
• Target: 1
• Locations: 1 country
• Sites: 1

Brief Summary

To compare the effects of total intravenous anesthesia and inhalation anesthesia used for maintenance on postoperative recovery in patients undergoing septorhinoplasty surgery under general anesthesia, using the recovery quality score (QoR-40).

Conditions

General Anesthesia; İnhalation Anesthetics; Quality of Recovery

Keywords

total intravenous anesthesia; anesthesia maintenance; inhalation anesthesia; quality of recovery-40

Outcome Measures

Primary Outcomes (1)

• quality of recovery-40 questionnaire

  measurement of recovery quality in the first 24 hours after extubation with quality of recovery-40 questionnaire. Quality of recovery-40 questionnaire scores range from 40 (extremely poor quality of recovery) to 200 (excellent quality of recovery).

  up to 24 hour after surgery

Secondary Outcomes (2)

• postoperative complications

  up to 24 hour after surgery

• duration of extubation

  end of the surgery

Study Arms (2)

Group TIVA

Procedure: maintenance of anesthesia

Group Inhalation

Procedure: maintenance of anesthesia

Interventions

maintenance of anesthesia PROCEDURE

Types used to maintain anesthesia

Group Inhalation; Group TIVA

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

The study will include intubated patients who will undergo septorhinoplasty surgery under general anesthesia, aged 18-65 years, in the American Society of Anesthesiology (ASA) I-II-III risk class.

You may qualify if:

• years old
• ASA I-II-III risk group
• Patients whose consent was obtained with an informed consent form
• Patients who will undergo septorhinoplasty surgery

You may not qualify if:

• ASA \>3
• Psychiatric illness that prevents them from answering the questionnaire
• Patients with a history of chronic opioid and benzodiazepine use as it may affect recovery time
• Severe renal and hepatic insufficiency
• Severe respiratory and cardiovascular disease
• Patients with a body mass index \>30 kg m2
• Patients with a known history of allergy or contraindication to any of the drugs to be used in the study

Sponsors & Collaborators

• Zonguldak Bulent Ecevit University: lead

Study Sites (1)

Zonguldak Bülent Ecevit University Medicine Faculty

Zonguldak, Kozlu, 67600, Turkey (Türkiye)

Location

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: May 3, 2024
• First Posted: May 21, 2024
• Study Start: May 1, 2024
• Primary Completion: November 30, 2024
• Study Completion: December 31, 2024
• Last Updated: April 22, 2025

Record last verified: 2025-04

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)